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Background: Lumbar disc disease (LDD) is one of the leading
causes of disability in the working-age population. A func-
tional single-nucleotide polymorphism (SNP), +1184TRC, in
exon 8 of the cartilage intermediate layer protein gene
(CILP) was recently identified as a risk factor for LDD in the
Japanese population (odds ratio (OR) 1.61, 95% CI 1.31 to
1.98), with implications for impaired transforming growth
factorb1 signalling.
Aim: To validate this finding in two different ethnic cohorts with
LDD.
Methods: This SNP and flanking SNPs were analysed in 243
Finnish patients with symptoms of LDD and 259 controls, and in
348 Chinese subjects with MRI-defined LDD and 343 controls.
Results and conclusion: The results showed no evidence of
association in the Finnish (OR = 1.35, 95% CI 0.97 to 1.87;
p = 0.14) or the Chinese (OR = 1.05, 95% CI 0.77 to 1.43;
p = 0.71) samples, suggesting that cartilage intermediate layer
protein gene is not a major risk factor for symptoms of LDD in
Caucasians or in the general population that included
individuals with or without symptoms.
L
umbar disc disease (LDD) is one of the leading causes of
disability in the working-age population. Radiological
changes indicative of LDD are common, but only a
proportion develops complications such as disc herniation and
sciatica. Although the aetiology of LDD is not well understood,
there is strong evidence for the involvement of both genetic and
environmental factors.1 2
A recent study reported an association between LDD and a
functional single-nucleotide polymorphism (SNP) (rs2073711),
+1184TRC, in exon 8 of the cartilage intermediate layer protein
gene (CILP) in a Japanese group (odds ratio (OR) 1.61, 95% CI
1.31 to –1.98).3 The allelic change resulted in amino acid
substitution Ile395Thr. CILP is expressed widely in interverteb-
ral discs and its expression increases as disc degeneration
progresses.3 CILP interacts directly with transforming growth
factor (TGF)b1, inhibiting the TGFb1-mediated induction of
extracellular matrix proteins such as aggrecan and collagen II.3
Functional studies showed that the C allele (coding for Thr395)
increased binding and inhibition of TGFb1, suggesting that
regulation of TGFb1 signalling by CILP plays a crucial role in
the aetiology and pathogenesis of LDD.3
Argument for a causal role would be strengthened if the
same association could be replicated in a distinct population,
and in clinical cases of LDD defined by MRI changes indicative
of LDD in general. Therefore, we investigated the association
between CILP polymorphisms and LDD in a Finnish sample
with symptoms of LDD, and in a Chinese sample with only
MRI-defined LDD. These samples were informative in previous
studies demonstrating association of LDD with the vitamin D
receptor gene4 and the Gln326Trp (Trp2) allele of COL9A25 in
Chinese and the Arg103Trp (Trp3) allele of COL9A3 in Finns.6
Thus, the Chinese sample is comparable with the Finnish
dataset, and a correlation can then be drawn with the Japanese
dataset.
METHODS
The Finnish cohort
The Finnish patient group consisted of 243 unrelated indivi-
duals (146 males, 97 females) with discogenic sciatica,
representing an extended set of one published previously.7 All
had unilateral pain radiating from the back to below the knee
(sciatica) from 3 weeks to 6 months (mean (SD) duration = 2.5
(1.5) months), which did not respond to non-steroidal anti-
inflammatory analgesics. The patients were examined clinically
and by MRI of the spine on enrolment and 3 years later.
Clinical presentation had to be concordant with MRI findings.
Approximately 5% of the cohort did not have a herniated disc
on MRI. In all, 29% of the subjects had been operated on for
herniated discs by the time of follow-up assessment.6 The
control group consisted of 259 unrelated individuals from the
same region of Finland (128 males, 131 females).
The Chinese cohort
In the Chinese sample set, the presence and severity of LDD
were assessed using Schneiderman’s classification8 for 691
individuals recruited from the general population. A score was
given for each lumbar level, with 0 indicating no degeneration
and 3 indicating a grossly degenerated disc with associated loss
of disc height.5 The MRIs were rated by two spine specialists
(KMCC and JK) independently, with good reliability.5 The sum
of the ratings for the five disc levels provides an overall raw
LDD score that is positively skewed and tends to increase in
mean and variance with age. To obtain standardised, age-
adjusted LDD scores, the raw LDD scores were logarithmically
transformed to reduce skewness and heteroscedasticity, and
then standardised to a mean of 0 and a variance of 1 in each
decade of age by subtracting the decade mean and dividing by
the decade SD. Finally, the sample was divided into two groups:
those with higher median age-adjusted scores were classified as
cases (n = 348) and those with lower scores were classified as
controls (n = 343).
As this new scoring system (with age adjustment) is different
from that used in a previous study,5 we investigated its validity.
In the previous analysis, an association between the Trp2 allele
and LDD was significant only after age stratification,5 suggest-
ing that the association is age-dependent. Using the new
scoring system, association was observed using a median split
(allelic p = 0.043), and became even more significant when the
extreme top and bottom 25% were compared (allelic p = 0.001).
Abbreviations: CILP, cartilage intermediate layer protein; LDD, lumbar
disc disease; SNP, single-nucleotide polymorphism; TGF, transforming
growth factor
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Genotype analysis
For the Finnish cohort, genomic DNA extracted from white
blood cells was used as a template for PCR. The recently
reported SNP, +1184 TRC (rs2073711) in exon 8, associating
with LDD was analysed by sequencing in all the 243 patients
and 259 controls. In addition, all exons, exon boundaries and
promoter regions of CILP were amplified by PCR and analysed
for sequence variations by sequencing. PCR amplifications were
typically performed using 20 ng of genomic DNA, 0.25 mM of
forward and reverse primers, 1.5 mM MgCl2, 0.2 mM dNTPs
and 1 U of Ampli Taq Gold polymerase (Applied Biosystems,
Foster City, California, USA). The PCR conditions included an
initial denaturation for 12 min at 95 C˚, 35 cycles at 95 C˚ for
30 s, at 58–64 C˚ for 30 s and at 72 C˚ for 30 s, followed by 1
cycle at 72 C˚ for 10 min. PCR products were sequenced using an
ABI PRISM 3100 sequencer and BigDye Terminator Sequencing
Kit (Applied Biosystems) to define the underlying sequence
variations.
For the Chinese cohort, the +1184 TRC SNP (rs2073711) and
three flanking SNPs (rs1561888, rs3784447 and rs4776680)
were genotyped using the Sequenom platform (Sequenom, San
Diego, California, USA). The Mass ARRAY AssayDesign soft-
ware (Sequenom) was used to design amplification and allele-
specific extension primers for uniplex or multiplexed assays.
The extension primer was designed to hybridise to the amplicon
near the SNP site for the extension of a single base or a few
bases depending on the genotype of the allele. PCRs treatment
of PCR products with alkaline phosphatase and mass extension
reactions were all performed according to the manufacturer’s
(Sequenom) protocol. The final base extension products were
desalted using SpectroClean resin (Sequenom), mixed with 3-
hydroxypicolinic acid, and analysed using a modified Brucker
Autoflex MALDI-TOF mass spectrometer (Brucker, Billerica,
Massachusetts, USA).
Statistical analysis
Genotype data of each SNP were checked for Hardy–Weinberg
disequilibrium using standard x2 goodness-of-fit tests.
Genotype data were then converted to allele counts in cases
(a, b) and allele counts in controls (c, d). These allele counts
were used to calculate OR (ad/bc), and 95% CI (using the
formula 1/a + 1/b +1/c + 1/d) for calculating the sampling
variance of the natural logarithm of the OR. The allele counts
were also subjected to Pearson’s x2 tests for association. These
analyses were done by implementing the formulae on an
EXCEL spreadsheet. In addition, analysis of variance testing for
differences in mean LDD scores between groups was done using
the SPSS software. Power calculations of the cohorts were
determined using a Genetic Power Calculator,9 assuming an OR
of 1.6 as found in the Japanese cohort.3
RESULTS
The Finnish cohort
Sequence analysis of the CILP SNP (rs2073711), +1184TRC in
exon 8, found no significant association, with an OR of 1.35
(95% CI 0.97 to 1.87) and a p value of 0.14 (table 1).
Furthermore, the frequencies of the corresponding
genotypes did not differ between the two groups (table 1).
Sequence analysis of the CILP promoter region, all exons and
exon boundaries detected five additional SNPs that are in
Hardy–Weinberg equilibrium, but all were present in both
patients and controls with similar frequency (data not
shown). Four of the variations were intronic at 245CRT
(intron 4), 212TRC (intron 6), 219TRC (intron 6) and
+19GRA (intron 6), and one was a synonymous change,
+3496GRA, in exon 9.
The Chinese cohort
Two SNPs in CILP (rs2073711 and rs1561888) and two in genes
flanking CLIP, rs3784447 in RASL12 and rs4776680 in PARP16,
were genotyped in this sample set. All four SNPs were in
Hardy–Weinberg equilibrium in both cases and controls. The
functional CILP SNP (rs2073771, +1184TRC in exon 8) had an
OR of only 1.05 (95% CI 0.77 to 1.43) and a p value of 0.71
(table 1). The frequencies of the corresponding genotypes did
not differ between the two groups (table 1). Furthermore,
similar results were obtained when more extreme cut-offs were
used for defining cases and controls (table 1), and when the
age-adjusted scores for SNP rs2073711 were treated as a
continuous variable in a regression analysis using analysis of
variance (F = 0.112, with p = 0.74). We also observed no
significant allelic association of another SNP (rs1561888)
within CILP or of SNPs flanking CILP (rs3784447 and
rs4776680) with LDD (data not shown).
Power calculation
Assuming a prevalence of 0.1–0.35 and an OR of 1.6 (per allele,
multiplicative risk model), we consider the power to be
reasonable with an estimate of over 80% for both the Chinese
and Finnish cohorts, for a significance level of 0.05.
DISCUSSION
Many of the candidate genes identified to be associated with
LDD are extracellular matrix components (recently reviewed by
Chan et al10). CILP is expressed in all structures of the
intervertebral discs, and its expression increases with progres-
sion in disc degeneration.3 Thus, the finding by Seki et al3
further highlights the importance of extracellular matrix
components in the aetiology of LDD, and the role of
extracellular matrix in the structural integrity of the tissue
and also in regulating signalling molecules in tissue repair and
maintenance. This finding opens new ideas for the search for
candidate genes for LDD as well as novel therapeutic
treatments that target specific pathways such as TGFb1
signalling. Its significance however needs validation in other
populations.
The lack of association in the current study does not imply
that the finding in the Japanese cohort is a false-positive result.
This is also unlikely, given the strong statistical power of the
study with a p value of 0.00002 following correction for
multiple testing.3 On the contrary, our findings add important
information to the Japanese study. In the Finnish set, the
recruitment criteria for disease and control groups were very
similar to those in the Japanese study. Thus, the disparity in
association with the CILP polymorphism may reflect ethnic
differences, suggesting that genetic risk factors for LDD are
likely to differ between the Japanese and Northern European
populations. This conclusion is supported by previous findings
of predisposing collagen IX alleles, Gln326Trp (Trp2) in the a2
chain5 11 and Arg103Trp (Trp3) in the a3 chain.6 Trp2 and Trp3
were found in about 5% and 24% of Finnish patients with LDD,
respectively. While Trp2 was found in about 20% of Southern
Chinese5 and Japanese12 individuals, Trp3 was absent in
Southern Chinese.5 Ethnic variations are further highlighted
in the different allele frequency of the rs20073711 SNP in CILP
between Japanese and Finnish populations.
Smaller ethnic differences are expected between Japanese
and Chinese, and this is reflected in the similar allele frequency
for the rs20073711 SNP in CILP. The major difference here is
the definition of LDD, wherein the Chinese sample set
comprises all individuals with LDD defined by MRI, indepen-
dently of symptoms. LDD is not always with symptoms, and
patients with sciatica represent only a small fraction, and
individuals requiring surgical invention are a further subset.
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Within the Chinese sample set, we also evaluated a small subset
of individuals who are clearly symptomatic versus controls with
herniation or sciatica and find no association, with p values of
0.42 and 0.83, respectively. Thus, the lack of association in the
Chinese sample suggests that the Japanese sample is not
representative of LDD in general but is a subset of individuals
with painful disc herniations.
Furthermore, we investigated the possibility that the
Japanese sample set represents an even more severe subset of
the disease by analysing a subset of 45 Finnish patients with
LDD who had undergone surgical treatment for herniated discs,
and found no association (data not shown). Given that the
criteria for patients with symptoms of LDD and controls are so
similar between the Japanese and Finnish samples, the lack of
association in Finns may suggest the presence of positive
modifiers for CILP or additional disposing factors in the
Japanese associated with CILP. However, with an estimated
power of around 80% for our cohorts, we cannot exclude the
possibility that the lack of association may be a type II error
(false negative), especially if the effect size in the Chinese and
Finnish populations is different from that reported for the
Japanese sample.
To ensure that we have not missed small effects, we
combined the data in a meta-analysis of the Finnish and
Chinese samples. The ORs from the two samples were
combined using an inverse variance weighting method. The
OR of the two samples was 1.15, with a 95% CI of 0.93 to 1.43,
again providing no evidence for an effect of CILP on LLD. Using
Fisher’s method of combining p values, the allele-wise tests of
the two samples (p = 0.14 for Finnish and p = 0.71 for Chinese)
gave an overall x2 statistic of 4.64 (4 df), and a non-significant
p value of 0.33.
A point of interest to note in the Japanese study3 is the
selective criteria of the cohort that consisted of 467 individuals
with degenerative disc disease and 654 controls. All of the
cases had a history of unilateral pain radiating from the back
along the femoral or sciatic nerve to the corresponding
dermatome of the nerve root for more than 3 months, all had
an MRI scan and 367 underwent surgical operation for lumbar
disc herniation to relieve symptomatic pain.3 Although it is
noted that degenerative changes are necessary for the disc to
herniate,13 it is also clear that herniation-induced pressure on
the nerve root alone cannot be the cause of pain, because over
70% of asymptomatic individuals have disc herniations
pressurising the nerve root but with no pain.14 15 Thus, the
Japanese cohort studied for the association of CILP3 may not
represent LDD in general, but a special extreme subset of
individuals with painful disc herniations.
In conclusion, we were unable to replicate the results of an
association between CILP and symptoms of lumbar disc
herniation found in the Japanese population. Although this
may suggest that the CILP association is unique in the Japanese
sample, it may be explained by other factors, including
differences in ethnicity and phenotype definition.
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